Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Tuccori · SciRah

Researcher profile · Semantic Scholar

M. Tuccori

Share profile

M. Tuccori — researcher profile on SciRah

h-index: 36
Works: 159
Citations: 4,060

Most-cited papers

Pioglitazone use and risk of bladder cancer: population based cohort study
M. Tuccori, K. Filion, Hui Yin, Oriana H. Y. Yu +2 more
2016British medical journal228 citations Open access
Semantic Scholar
Monoclonal antibody therapies against SARS-CoV-2
D. Focosi, S. McConnell, A. Casadevall, E. Cappello +2 more
2022Lancet. Infectious Diseases (Print)202 citations Open access
Semantic Scholar
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.
L. Antonioli, R. Colucci, C. La Motta, M. Tuccori +4 more
2012Current Drug Targets176 citations
Semantic Scholar
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care
R. E. Kast, J. Boockvar, A. Brüning, F. Cappello +24 more
2013OncoTarget174 citations Open access
Semantic Scholar
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
M. Tuccori, S. Ferraro, I. Convertino, E. Cappello +4 more
2020mAbs149 citations Open access
Semantic Scholar
Convalescent Plasma Therapy for COVID-19: State of the Art
D. Focosi, A. Anderson, J. Tang, M. Tuccori
2020Clinical Microbiology Reviews122 citations Open access
Semantic Scholar
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System
E. Raschi, A. Mazzarella, I. Antonazzo, Nicolò Bendinelli +5 more
2019Targeted oncology90 citations
Semantic Scholar
Progressive multifocal leukoencephalopathy and anti‐CD20 monoclonal antibodies: What do we know after 20 years of rituximab
D. Focosi, M. Tuccori, F. Maggi
2019Reviews in Medical Virology80 citations
Semantic Scholar
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
M. Tuccori, I. Convertino, S. Ferraro, E. Cappello +3 more
2020Drug Safety70 citations Open access
Semantic Scholar
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications.
L. Antonioli, R. Colucci, C. Pellegrini, G. Giustarini +3 more
2013Pharmacology and Therapeutics65 citations
Semantic Scholar
Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance
M. Sardella, G. Belcher, Calin Lungu, T. Ignoni +23 more
2021Therapeutic Advances in Drug Safety58 citations Open access
Semantic Scholar
Neuropsychiatric Adverse Events Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management
M. Tuccori, S. Montagnani, Stefania Mantarro, A. Capogrosso-Sansone +5 more
2014CNS Drugs58 citations
Semantic Scholar
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients
I. Convertino, M. Tuccori, S. Ferraro, G. Valdiserra +3 more
2020Critical Care56 citations Open access
Semantic Scholar
Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum
J. Beckmann, U. Hagemann, P. Bahri, A. Bate +14 more
2014Drug Safety53 citations Open access
Semantic Scholar
Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome
R. Colucci, D. Gambaccini, N. Ghisu, G. Rossi +10 more
2013PLoS ONE53 citations Open access
Semantic Scholar
Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats
L. Antonioli, M. Giron, R. Colucci, C. Pellegrini +7 more
2014PLoS ONE49 citations Open access
Semantic Scholar
NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?
M. Fornai, L. Antonioli, R. Colucci, C. Pellegrini +9 more
2014Journal of Pharmacology and Experimental Therapeutics49 citations
Semantic Scholar
Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy
N. Lombardi, G. Crescioli, A. Bettiol, M. Tuccori +10 more
2019Frontiers in Pharmacology37 citations Open access
Semantic Scholar
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
D. Focosi, M. Tuccori, A. Baj, F. Maggi
2021Viruses36 citations Open access
Semantic Scholar
The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes
M. Tuccori, Jennifer W. Wu, Hui Yin, A. Majdan +1 more
2015Diabetes Care33 citations Open access
Semantic Scholar
Role of the A2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats
L. Antonioli, M. Fornai, O. Awwad, G. Giustarini +10 more
2014British Journal of Pharmacology33 citations Open access
Semantic Scholar
The usefulness of listening social media for pharmacovigilance purposes: a systematic review
I. Convertino, S. Ferraro, C. Blandizzi, M. Tuccori
2018Expert Opinion on Drug Safety32 citations Open access
Semantic Scholar
Allopurinol adherence among patients with gout: an Italian general practice database study
Stefania Mantarro, Alice Capogrosso-Sansone, M. Tuccori, C. Blandizzi +8 more
2015International journal of clinical practice32 citations
Semantic Scholar
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)
N. Lombardi, G. Crescioli, A. Bettiol, M. Tuccori +6 more
2020Frontiers in Pharmacology31 citations Open access
Semantic Scholar
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection
M. Tuccori, S. Montagnani, A. Capogrosso-Sansone, Stefania Mantarro +3 more
2015Expert Review of Clinical Pharmacology30 citations
Semantic Scholar
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects
I. Convertino, A. Sansone, Alessandra Marino, M. T. Galiulo +5 more
2016Drug Safety27 citations Open access
Semantic Scholar
An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting
S. Crisafulli, Zakir Khan, Yusuf Karataş, M. Tuccori +1 more
2023Expert Opinion on Drug Safety26 citations
Semantic Scholar
The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
D. Focosi, M. Tuccori, M. Franchini
2021Life25 citations Open access
Semantic Scholar
Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine
M. Rossi, Federico Marzi, M. Natale, Aristotele Porceddu +4 more
2021Drugs - Real World Outcomes23 citations Open access
Semantic Scholar
Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy
D. Focosi, M. Tuccori
2022Pathogens21 citations Open access
Semantic Scholar
Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments
G. Crescioli, A. Bettiol, R. Bonaiuti, M. Tuccori +9 more
2021Frontiers in Pharmacology20 citations Open access
Semantic Scholar
Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
Alice Capogrosso Sansone, Stefania Mantarro, M. Tuccori, E. Ruggiero +8 more
2015Drug Safety20 citations Open access
Semantic Scholar
Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation
G. Antonelli, D. Focosi, O. Turriziani, M. Tuccori +5 more
2022Clinical Microbiology and Infection18 citations Open access
Semantic Scholar
Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
S. Ferraro, L. Leonardi, I. Convertino, C. Blandizzi +1 more
2019Frontiers in Pharmacology17 citations Open access
Semantic Scholar
Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database
Alice Capogrosso Sansone, I. Convertino, M. T. Galiulo, S. Salvadori +7 more
2017Drug Safety17 citations
Semantic Scholar
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.
I. Martinucci, C. Blandizzi, N. de Bortoli, M. Bellini +5 more
2015Pharmacogenomics (London)17 citations Open access
Semantic Scholar
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review
M. Franchini, E. Cappello, G. Valdiserra, M. Bonaso +3 more
2022Seminars in Thrombosis and Hemostasis16 citations Open access
Semantic Scholar
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future
M. Tuccori, I. Convertino, S. Ferraro, G. Valdiserra +3 more
2021Expert Opinion on Drug Discovery16 citations Open access
Semantic Scholar
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials
F. Ahmadizar, N. Luxi, Monika Raethke, S. Schmikli +119 more
2023Drug Safety15 citations Open access
Semantic Scholar
Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis
I. Convertino, S. Salvadori, Alessandro Pecori, M. T. Galiulo +6 more
2018Drug Safety15 citations
Semantic Scholar
Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review
D. Focosi, M. Franchini, M. Tuccori, M. Cruciani
2022Vaccines14 citations Open access
Semantic Scholar
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons.
I. Convertino, E. Lucenteforte, R. Gini, V. Lorenzoni +10 more
2020Clinical and Experimental Rheumatology12 citations
Semantic Scholar
Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery
A. Bate, J. Beckmann, A. Dodoo, L. Härmark +6 more
2017Drug Safety12 citations Open access
Semantic Scholar
Telogen Effluvium following Bivalent Human Papillomavirus Vaccine Administration: A Report of Two Cases
M. Tuccori, C. Pisani, L. Bachini, Milena Pardini +6 more
2012Dermatology11 citations
Semantic Scholar
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
A. Pugi, R. Bonaiuti, V. Maggini, M. Moschini +10 more
2013American Journal of Health-System Pharmacy10 citations Open access
Semantic Scholar
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward
Giovanni Furlan, P. Caduff-Janosa, L. Sottosanti, E. Cappello +2 more
2020Drug Safety9 citations
Semantic Scholar
Hepatitis C virus infection: opportunities for an earlier detection in primary care
F. Lapi, Alice Capogrosso Sansone, Stefania Mantarro, M. Simonetti +9 more
2017European Journal of Gastroenterology and Hepathology9 citations
Semantic Scholar
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases
I. Convertino, M. Cazzato, S. Giometto, R. Gini +15 more
2021Scientific Reports8 citations Open access
Semantic Scholar
Quality of Adverse Drug Reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance
M. Tuccori, G. Giustarini, C. Blandizzi, A. Capogrosso-Sansone +9 more
2013Journal of public health8 citations
Semantic Scholar
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence
I. Convertino, S. Ferraro, E. Cappello, G. Valdiserra +2 more
2023Expert Opinion on Drug Discovery7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Blandizzi×24
Invite
C. Blandizzi — researcher profile on SciRah
D. Focosi×14
Invite
D. Focosi — researcher profile on SciRah
L. Antonioli×14
Invite
L. Antonioli — researcher profile on SciRah
M. Fornai×14
Invite
M. Fornai — researcher profile on SciRah

×13

Invite

I. Convertino — researcher profile on SciRah

Invite

S. Ferraro — researcher profile on SciRah

Invite

E. Cappello — researcher profile on SciRah

G. Valdiserra×9

Invite

G. Valdiserra — researcher profile on SciRah

Stefania Mantarro×8

Invite

Stefania Mantarro — researcher profile on SciRah

Invite

R. Colucci — researcher profile on SciRah

Invite

A. Vannacci — researcher profile on SciRah

S. Montagnani×5

Invite

S. Montagnani — researcher profile on SciRah